Cargando…

Utility of blood procalcitonin concentration in the management of cancer patients with infections

Diagnosis of infections in cancer patients is usually problematic since differentiating between infection and fever of unknown origin is often a considerable clinical challenge. In general, increase concentration of blood procalcitonin (PCT) is associated with severe bacterial infection. PCT with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Durnaś, Bonita, Wątek, Marzena, Wollny, Tomasz, Niemirowicz, Katarzyna, Marzec, Michał, Bucki, Robert, Góźdź, Stanisław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731001/
https://www.ncbi.nlm.nih.gov/pubmed/26858528
http://dx.doi.org/10.2147/OTT.S95600
_version_ 1782412500569948160
author Durnaś, Bonita
Wątek, Marzena
Wollny, Tomasz
Niemirowicz, Katarzyna
Marzec, Michał
Bucki, Robert
Góźdź, Stanisław
author_facet Durnaś, Bonita
Wątek, Marzena
Wollny, Tomasz
Niemirowicz, Katarzyna
Marzec, Michał
Bucki, Robert
Góźdź, Stanisław
author_sort Durnaś, Bonita
collection PubMed
description Diagnosis of infections in cancer patients is usually problematic since differentiating between infection and fever of unknown origin is often a considerable clinical challenge. In general, increase concentration of blood procalcitonin (PCT) is associated with severe bacterial infection. PCT with an optimal cutoff level of 0.5 ng/mL seems to be the most helpful biochemical parameter in detecting severe infections, mainly bloodstream infection, in patients with hematological cancers. In all clinical situations, the elevated level of PCT should be carefully analyzed, always with a thorough physical examination and an appropriate microbiological assessment.
format Online
Article
Text
id pubmed-4731001
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47310012016-02-08 Utility of blood procalcitonin concentration in the management of cancer patients with infections Durnaś, Bonita Wątek, Marzena Wollny, Tomasz Niemirowicz, Katarzyna Marzec, Michał Bucki, Robert Góźdź, Stanisław Onco Targets Ther Review Diagnosis of infections in cancer patients is usually problematic since differentiating between infection and fever of unknown origin is often a considerable clinical challenge. In general, increase concentration of blood procalcitonin (PCT) is associated with severe bacterial infection. PCT with an optimal cutoff level of 0.5 ng/mL seems to be the most helpful biochemical parameter in detecting severe infections, mainly bloodstream infection, in patients with hematological cancers. In all clinical situations, the elevated level of PCT should be carefully analyzed, always with a thorough physical examination and an appropriate microbiological assessment. Dove Medical Press 2016-01-22 /pmc/articles/PMC4731001/ /pubmed/26858528 http://dx.doi.org/10.2147/OTT.S95600 Text en © 2016 Durnaś et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Durnaś, Bonita
Wątek, Marzena
Wollny, Tomasz
Niemirowicz, Katarzyna
Marzec, Michał
Bucki, Robert
Góźdź, Stanisław
Utility of blood procalcitonin concentration in the management of cancer patients with infections
title Utility of blood procalcitonin concentration in the management of cancer patients with infections
title_full Utility of blood procalcitonin concentration in the management of cancer patients with infections
title_fullStr Utility of blood procalcitonin concentration in the management of cancer patients with infections
title_full_unstemmed Utility of blood procalcitonin concentration in the management of cancer patients with infections
title_short Utility of blood procalcitonin concentration in the management of cancer patients with infections
title_sort utility of blood procalcitonin concentration in the management of cancer patients with infections
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731001/
https://www.ncbi.nlm.nih.gov/pubmed/26858528
http://dx.doi.org/10.2147/OTT.S95600
work_keys_str_mv AT durnasbonita utilityofbloodprocalcitoninconcentrationinthemanagementofcancerpatientswithinfections
AT watekmarzena utilityofbloodprocalcitoninconcentrationinthemanagementofcancerpatientswithinfections
AT wollnytomasz utilityofbloodprocalcitoninconcentrationinthemanagementofcancerpatientswithinfections
AT niemirowiczkatarzyna utilityofbloodprocalcitoninconcentrationinthemanagementofcancerpatientswithinfections
AT marzecmichał utilityofbloodprocalcitoninconcentrationinthemanagementofcancerpatientswithinfections
AT buckirobert utilityofbloodprocalcitoninconcentrationinthemanagementofcancerpatientswithinfections
AT gozdzstanisław utilityofbloodprocalcitoninconcentrationinthemanagementofcancerpatientswithinfections